(Q33532632)

English

Two years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 July 2017

Two years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal (English)

1 reference

Europe PubMed Central

27 July 2017

hypercholesterolemia

0 references

familial hypercholesterolemia

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

27 July 2017

John J. P. Kastelein

6

object named as

John J P Kastelein

1 reference

Europe PubMed Central

27 July 2017

author name string

Roeland Huijgen

1

1 reference

Europe PubMed Central

27 July 2017

Iris Kindt

2

1 reference

Europe PubMed Central

27 July 2017

Sjoerd B J Verhoeven

3

1 reference

Europe PubMed Central

27 July 2017

Maud N Vissers

5

1 reference

Europe PubMed Central

27 July 2017

Barbara A Hutten

7

1 reference

Europe PubMed Central

27 July 2017

language of work or name

0 references

publication date

15 February 2010

1 reference

Europe PubMed Central

27 July 2017

1 reference

Europe PubMed Central

27 July 2017

5

1 reference

Europe PubMed Central

27 July 2017

2

1 reference

Europe PubMed Central

27 July 2017

e9220

1 reference

Europe PubMed Central

27 July 2017

copyright license

Creative Commons Attribution 4.0 International

15 February 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Efficacy of statins in familial hypercholesterolaemia: a long term cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821409

21 June 2018

Familial hypercholesterolemia: current treatment and advances in management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821409

21 June 2018

Simvastatin with or without ezetimibe in familial hypercholesterolemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821409

21 June 2018

The efficacy and safety of intensive statin therapy: a meta-analysis of randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821409

21 June 2018

Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821409

21 June 2018

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821409

21 June 2018

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821409

21 June 2018

Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821409

21 June 2018

Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821409

21 June 2018

Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821409

21 June 2018

Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821409

21 June 2018

Long-term compliance with lipid-lowering medication after genetic screening for familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0009220

21 January 2018

Update of the molecular basis of familial hypercholesterolemia in The Netherlands

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0009220

21 January 2018

Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0009220

21 January 2018

Are patients with familial hypercholesterolaemia well managed in lipid clinics? An audit of eleven clinics from the Department of Health Familial Hypercholesterolaemia Cascade Testing project.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0009220

21 January 2018

Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0009220

21 January 2018

The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0009220

21 January 2018

Familial hypercholesterolaemia: summary of NICE guidance

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0009220

21 January 2018

Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821409

31 October 2018

Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2821409

31 October 2018

Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriocslerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20169164

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of LDL-receptor mutation type on age at first cardiovascular event in patients with familial hypercholesterolaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20169164

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The practice guideline 'Diagnosis and treatment of familial hypercholesterolaemia' of the Dutch Health Care Insurance Board]

1 reference

https://pubmed.ncbi.nlm.nih.gov/20169164

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Familial defective apolipoprotein B and familial hypobetalipoproteinemia in one family: two neutralizing mutations

1 reference

https://pubmed.ncbi.nlm.nih.gov/20169164

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0009220

1 reference

Europe PubMed Central

27 July 2017

2010PLoSO...5.9220H

0 references

1 reference

Europe PubMed Central

27 July 2017

1 reference

Europe PubMed Central

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33532632&oldid=1978552033"